Glioblastoma is a very aggressive brain tumor that has few treatment options. Its prognosis is very poor, and research has been less successful than in other cancers.

A key part of current glioblastoma treatment is surgery to remove as much of the tumor as possible safely. This is called maximal safe resection.

Access to the latest research

Glioblastoma is a deadly brain cancer that affects approximately 200,000 people a year. It is difficult to treat because the tumor mixes with healthy brain tissue. It is also very fast-growing and has a poor survival rate.

This is why it is so important that patients have access to the latest research and clinical trials. Glioblastoma Foundation professionals are dedicated to advancing research and providing patients with the most up-to-date information so that they can make the best treatment decision possible for their unique situation.

Access to clinical trials

Glioblastoma is a very aggressive form of brain cancer. It grows into and mixes with healthy brain tissue, making it difficult to treat.

Special tests can help doctors identify the unique characteristics of glioblastoma on a molecular level. This information can support the creation of a personalized treatment plan.

The current standard of care for glioblastoma is maximum safe surgical resection followed by radiation and chemotherapy (including Temozolomide or Temodar). Several clinical trials are testing different combinations and approaches to improve patient outcomes.

Several barriers to the development of effective glioblastoma therapies remain. For example, overly restrictive trial eligibility criteria limit patients’ participation in research. There is increasing recognition of the need to broaden eligibility for brain tumor trials.

Access to patient support

Glioblastoma (GBM) is a fast-growing brain tumor that typically impacts adults. This type of brain cancer develops from glial cells in the brain and is considered an aggressive form of the disease.

GBM is a difficult tumor to treat and is one of America’s most common causes of brain cancer deaths. This is largely because this tumor often mixes with healthy tissue, making it very difficult to treat.

Glioblastoma Foundation professionals can help patients navigate their treatment journey by providing valuable information about glioblastoma and access to medical experts. This can improve patient outcomes by enabling patients and their caregivers to vocalize their goals, expectations, and values with HCPs and ultimately result in goal alignment and treatment planning that is more patient-centric.

Access to financial assistance

A glioblastoma diagnosis can potentially cause tremendous financial strain on patients and their families. Even with the best health insurance, co-pays, and other out-of-pocket expenses can add up quickly.

The PAN Foundation Glioblastoma Multiforme Fund is designed to help federally and commercially insured patients with life-threatening brain tumors, such as glioblastoma, with the costs of their prescribed medications. Eligible patients will receive up to $1,600 per year in assistance.

You can help us make a bigger impact on GBM research by becoming a fundraiser! There are several ways to raise funds, such as hosting a party or running your favorite race. You can also honor a GBM Warrior by creating an Honor Fund in their name. For more information, click here.

Access to educational resources

Glioblastoma Foundation has a range of educational resources that our patients, families, and schools can access. Returning to nursery, school, or college after a brain tumor diagnosis can be particularly challenging for children, with a loss of attainment, changing ability levels, and difficulties adapting socially and emotionally. Our educational resources help support teachers and staff in their work with children who have experienced a brain tumor.